No label defined (Q30580)

From lgbtDB
Jump to navigation Jump to search
No description defined
  • Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands' ATHENA observational cohort.
Language Label Description Also known as
English
No label defined
No description defined
  • Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands' ATHENA observational cohort.

Statements

Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands' ATHENA observational cohort. (English)
1 reference
Transgender women are at increased risk of acquiring HIV. (English)
1 reference
Earlier studies reported lower retention in HIV care, antiretroviral therapy uptake, adherence and viral suppression. (English)
1 reference
We assessed the stages of the HIV care continuum of transgender women in the Netherlands over an 11-year period. (English)
1 reference
In addition, we assessed new HIV diagnoses and late presentation, as well as disengagement from care, between 2011 and 2021. (English)
1 reference
Using data from the Dutch national ATHENA cohort, we separately assessed viral suppression, as well as time to achieving viral suppression, among transgender women for each year between 2011 and 2021. (English)
1 reference
We also assessed trends in new HIV diagnoses and late presentation (CD4 count of <350 cells/µl and/or AIDS at diagnosis), and disengagement from care. (English)
1 reference
Between 2011 and 2021, a total of 260 transgender women attended at least one HIV clinical visit. (English)
1 reference
Across all years, <90% of transgender women were virally suppressed (207/239 [87%] in 2021). (English)
1 reference
The number of new HIV diagnoses fluctuated for transgender women (p<sub>trend</sub> = 0.053) and late presentation was common (ranging between 10% and 67% of new HIV diagnoses). (English)
1 reference
Of the 260 transgender women, 26 (10%) disengaged from care between 2011 and 2021 (incidence rate = 1.10 per 100 person-years, 95% confidence interval = 0.75-1.61). (English)
1 reference
Between 2011 and 2021, less than 90% of transgender women linked to HIV care were virally suppressed. (English)
1 reference
Late presentation at the time of diagnosis and disengagement from care were common. (English)
1 reference
Efforts are needed to identify barriers to early HIV diagnosis and to optimize the different steps across the care continuum for transgender women. (English)
1 reference
August 2024
1 reference
August 2024
1 reference
ATHENA observational HIV cohort (English)
1 reference
27
1 reference
8
1 reference
e26317
1 reference
e26317
1 reference
unknown value
1 reference
EH received unrestricted research grants from Gilead Sciences paid to her institute. (English)
1 reference
MP received unrestricted research grants and speaker's fees from Gilead Sciences, Abbvie and MSD, all of which were paid to her institute and unrelated to the current work. (English)
1 reference
MSvdL served on an Advisory Board of MSD, paid to his institute and unrelated to the current work. (English)
1 reference
PR has received grant support through his institution for investigator‐initiated research unrelated to the current work from Gilead Sciences, ViiV Healthcare and Merck & Co, and has served on scientific advisory boards of Gilead Sciences, ViiV Healthcare and Merck & Co, honoraria for which were paid to his institution. (English)
1 reference
All other authors declare no competing interests. (English)
1 reference